Finasteride for Recurrent Priapism in Children and Adolescents: A Report on 5 Cases

October 2012 in “ International Braz J Urol ”

Ubirajara Barroso, Thamy Cristine Santana Marques, Hugo Novaes

finasteride sickle cell disease priapism Propecia

TLDR Finasteride effectively and safely treats recurrent priapism in children and adolescents with sickle cell disease.

The study evaluated the use of finasteride in children and adolescents with sickle cell disease who experienced recurrent priapism. The study found that a low daily dose of finasteride appears to represent an effective and safe form of treatment for recurrent priapism in children and adolescents with SCD. After treatment, four patients had no episodes of priapism, and one patient reported stuttering priapism. No side effects were reported, and all patients reported normal, full erections. The authors recommend that finasteride be used in selected cases only and in low doses for a short period of time.

View this study on scielo.br →

Discuss this study in the Community →

Research cited in this study

1 / 1 results

research Treatment of Recurrent Priapism in Sickle Cell Anemia With Finasteride: A New Approach

57 citations, July 2009 in “Urology”

Finasteride helps reduce priapism in sickle cell anemia patients.

Related Community Posts Join

6 / 1000+ results

community CRISPR Is Curing People Right Now. Genetic Hair Loss is Next?

in Technology 107 upvotes 2 months ago

CRISPR shows promise for treating hair loss by targeting specific genes. Current treatments include Minoxidil and finasteride, but CRISPR could offer a more precise solution, though it is still expensive and in early stages.

community So we have 20k dollars human like machines available but no new effective treatment for hairloss since finasteride :)

in Chat 237 upvotes 2 months ago

There have been no new effective hair loss treatments since finasteride, despite technological advancements. Current treatments include finasteride, minoxidil, and RU58841, with ongoing challenges and potential future solutions in research.

community A year of fin+min(23yo), got my life back

in Progress Pictures 2187 upvotes 1 year ago

A 23 year old user who has had success with finasteride and minoxidil, regaining their hair after losing it due to male pattern baldness. They also attribute part of the success to lifestyle changes such as eating better, exercising, sleeping well, and reducing smoking.

community I believe CRISPR-on & CRISPR-off is an ultimate CURE for baldness, unlike Hair Cloning or hair loss treatments.

in Research/Science 22 upvotes 3 years ago

The conversation discusses CRISPR-on & CRISPR-off as a potential cure for baldness, contrasting it with hair cloning and other treatments like Minoxidil, finasteride, and RU58841. It also mentions the potential of mRNA for gene expression control and the prioritization of gene editing for severe genetic conditions.

community IT ABSOLUTELY FUCKING SUCKS to be going through this in silence while my roommates/best friends don't have to worry about this.

in Chat 145 upvotes 4 years ago

The conversation is about a person struggling with hair loss and feeling frustrated comparing themselves to friends with thick hair. They started taking 1 mg Finasteride a month ago to address the hair loss.

community In my opinion baldness is more prevalent now and it's being ignored..

in Chat 236 upvotes 1 year ago

The conversation is about the prevalence of baldness among young men and the potential factors contributing to it. Specific treatments mentioned include minoxidil and finasteride.

Related Research

2 / 2 results

research Finasteride for Recurrent Priapism in Children and Adolescents: A Report on 5 Cases

12 citations, October 2012 in “International Braz J Urol”

Finasteride effectively and safely treats recurrent priapism in children and adolescents with sickle cell disease.

research Treatment of Recurrent Priapism in Sickle Cell Anemia With Finasteride: A New Approach

57 citations, July 2009 in “Urology”

Finasteride helps reduce priapism in sickle cell anemia patients.